Altium Capital Management »

Cybin Ord shares owned by Altium Capital Management

Quarter-by-quarter ownership of Cybin Ord (CYBN) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Cybin Ord

Tip: Access up to 7 years of quarterly data

All positions including Cybin Ord held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin Ord by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.8M 14M 0.27
2024-03-31 $5.8M 14M 0.41

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Adma Biologics (ADMA)
Xenon Pharmaceuticals (XENE)
Intra Cellular Therapies (ITCI)
Sarepta Therapeutics (SRPT)
Insmed Com Par $.01 (INSM)
Alimera Sciences Com New
Skye Bioscience Com New (SKYE)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Avadel Pharmaceuticals Com Shs (AVDL)
Catalyst Pharmaceutical Partners (CPRX)
Contineum Therapeutics Cl A (CTNM)
Rezolute Com New (RZLT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for Altium Capital Management

Top funds holding Cybin Ord

Deep Track Capital
Logos Global Management
Sphera Funds Management
Altium Capital Management
AdvisorShares Investments
Rosalind Advisors
Propel Bio Management
Stifel Financial
Sanctuary Advisors
Morgan Stanley
Rathbones Brothers
Cardiff Park Advisors
Mercer Global Advisors
Emfo
HighTower Advisors

View all funds holding Cybin Ord